BG40318A3 - Метод за получаване на имуноглобулинови производни на виндезина - Google Patents
Метод за получаване на имуноглобулинови производни на виндезинаInfo
- Publication number
- BG40318A3 BG40318A3 BG054907A BG5490782A BG40318A3 BG 40318 A3 BG40318 A3 BG 40318A3 BG 054907 A BG054907 A BG 054907A BG 5490782 A BG5490782 A BG 5490782A BG 40318 A3 BG40318 A3 BG 40318A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- vindesin
- immunoglobulin derivatives
- obtaining immunoglobulin
- derivatives
- obtaining
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8100847 | 1981-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG40318A3 true BG40318A3 (bg) | 1986-11-14 |
Family
ID=10518931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG054907A BG40318A3 (bg) | 1981-01-12 | 1982-01-08 | Метод за получаване на имуноглобулинови производни на виндезина |
Country Status (27)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639456A (en) * | 1980-06-10 | 1987-01-27 | Omnichem S.A. | Vinblastin-23-oyl amino acid derivatives |
| CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
| DE3482444D1 (de) * | 1983-03-30 | 1990-07-19 | Lilly Industries Ltd | Immunoglobulinkonjugate. |
| EP0123441B1 (en) * | 1983-03-30 | 1990-10-03 | Lilly Industries Limited | Vincaleukoblastine derivatives |
| EP0124502B1 (fr) * | 1983-04-29 | 1991-06-12 | OMNICHEM Société anonyme | Nouveaux conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques contenant ces conjugués |
| GB2148299B (en) * | 1983-09-01 | 1988-01-06 | Hybritech Inc | Antibody compositions of therapeutic agents having an extended serum half-life |
| US4667030A (en) * | 1985-06-17 | 1987-05-19 | Eli Lilly And Company | Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| FI860456A7 (fi) * | 1985-07-16 | 1987-01-17 | Huhtamaeki Oy Laeaeketehdas Le | Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning. |
| EP0232693A3 (fr) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
| IL82579A0 (en) * | 1986-05-27 | 1987-11-30 | Lilly Co Eli | Immunoglobulin conjugates |
| FR2626882B1 (fr) * | 1988-02-08 | 1991-11-08 | Ire Celltarg Sa | Conjugues de derives de vinca comportant une chaine detergente en position c-3 |
| US5094849A (en) * | 1988-08-08 | 1992-03-10 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers |
| US5006652A (en) * | 1988-08-08 | 1991-04-09 | Eli Lilly And Company | Intermediates for antibody-vinca drug conjugates |
| US5144012A (en) * | 1988-08-08 | 1992-09-01 | Eli Lilly And Company | Cytotoxic drug conjugates |
| US5028697A (en) * | 1988-08-08 | 1991-07-02 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
| US5043340A (en) * | 1990-04-03 | 1991-08-27 | Eli Lilly And Company | Derivatives of 4-desacetyl VLB C-3 carboxhydrazide |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2456224A1 (de) * | 1974-11-28 | 1976-08-12 | Karl Dr Med Theurer | Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie |
| GB1446536A (en) * | 1975-02-21 | 1976-08-18 | Yeda Res & Dev | Pharmaceutically active compositions |
| FR2349335A1 (fr) * | 1976-04-28 | 1977-11-25 | Inst Int Pathologie Cellulaire | Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation |
| EP0000938B1 (en) * | 1977-08-22 | 1984-10-17 | National Research Development Corporation | Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them |
| FR2437213A1 (fr) * | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
| JPS55136235A (en) * | 1979-04-09 | 1980-10-23 | Teijin Ltd | Antitumor protein complex and its preparation |
-
1982
- 1982-01-05 FI FI820020A patent/FI820020A7/fi not_active Application Discontinuation
- 1982-01-06 NZ NZ199421A patent/NZ199421A/en unknown
- 1982-01-06 EG EG8207A patent/EG15599A/xx active
- 1982-01-07 RO RO105259A patent/RO82758B/ro unknown
- 1982-01-07 AU AU79274/82A patent/AU549495B2/en not_active Ceased
- 1982-01-07 PT PT74252A patent/PT74252B/pt unknown
- 1982-01-07 PH PH26708A patent/PH18031A/en unknown
- 1982-01-07 IL IL64722A patent/IL64722A/xx unknown
- 1982-01-07 IE IE23/82A patent/IE52239B1/en unknown
- 1982-01-08 DK DK5982A patent/DK5982A/da not_active Application Discontinuation
- 1982-01-08 DD DD82236636A patent/DD201447A5/de unknown
- 1982-01-08 ZA ZA82122A patent/ZA82122B/xx unknown
- 1982-01-08 BG BG054907A patent/BG40318A3/xx unknown
- 1982-01-11 JP JP57002635A patent/JPS57136529A/ja active Pending
- 1982-01-11 CS CS82226A patent/CS235525B2/cs unknown
- 1982-01-11 CA CA000393880A patent/CA1180660A/en not_active Expired
- 1982-01-11 MX MX829866U patent/MX7215E/es unknown
- 1982-01-11 DE DE8282300116T patent/DE3267474D1/de not_active Expired
- 1982-01-11 GB GB8200663A patent/GB2090837B/en not_active Expired
- 1982-01-11 EP EP82300116A patent/EP0056322B1/en not_active Expired
- 1982-01-11 SU SU823378149A patent/SU1069628A3/ru active
- 1982-01-11 AT AT82300116T patent/ATE16603T1/de not_active IP Right Cessation
- 1982-01-11 HU HU8265A patent/HU186025B/hu unknown
- 1982-01-11 ES ES508633A patent/ES8304149A1/es not_active Expired
- 1982-01-12 KR KR8200104A patent/KR860001149B1/ko not_active Expired
- 1982-01-12 GR GR66989A patent/GR75182B/el unknown
- 1982-01-12 PL PL1982234695A patent/PL128529B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG40318A3 (bg) | Метод за получаване на имуноглобулинови производни на виндезина | |
| BG40654A3 (bg) | Метод за получаване на циклоалкилтриазоли | |
| NL7904926A (nl) | Werkwijze ter bereiding van synthesegas. | |
| MX9203820A (es) | Ultrapurificacion del factor viii utilizando anticuerpos monoclonales. | |
| BG40651A3 (en) | Method for preparing (1- arylcyclobutyl) alkylamines | |
| FI810459A7 (fi) | Menetelmä olefiinien valmistamiseksi. | |
| BG38487A3 (en) | Method for preparing peptides | |
| IT7824577A0 (it) | Metodo per la produzione di anticorpi. | |
| BG35330A3 (bg) | Метод за получаване на 3-йодметилцефалоспорини | |
| BG40815A3 (bg) | Метод за получаване на пептиди | |
| BG35328A3 (en) | Method for preparing imidodisulphamidic derivatives | |
| BG34908A3 (bg) | Метод за получаване на d- 6- n- пропилерголини | |
| BG42185A3 (en) | Method for preparing pyridylic compounds | |
| BG41124A3 (en) | Method for preparing benzamides | |
| EP0257778A3 (en) | Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas | |
| BG32856A3 (bg) | Метод за получаване на 1-оксадетилацефалоспорий | |
| BG40807A3 (en) | Method for preparing n- phenylcarbamates | |
| BG36932A3 (bg) | Метод за получаване на 1-(3-хидрокси-4-метаксибензоил)-3- хидрокси-2-пиролидинон | |
| BG40803A3 (bg) | Метод за получаване на арилциклобутилалкиламинови производни | |
| BG38637A3 (en) | Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes | |
| BG36935A3 (en) | Method for preparing benzodiazepine compounds | |
| BG38940A3 (en) | Method for preparing penicillanoyloxymethyl penicillanate- 1, 1- dioxide | |
| BG38337A3 (en) | Method for preparing 6 alpha- methylhydrocortisonic derivatives | |
| BG35045A3 (bg) | Метод за получаване на заместени триарилтиазолови съединения | |
| BG35895A3 (en) | Method for preparing of n- substituted- 2- haloacetanilides |